The UK has launched a five-year action plan and 20-year vision for antimicrobial resistance (AMR). More: Antimicrobial resistance "as big a danger to humanity as climate change or warfare" Source: News
read moreNovo Nordisk says it has planned for all future ‘no-deal’ Brexit contingencies, including doubling UK stock to 16 weeks (around four months of supply), which will be in place by the end of January. More: Novo Nordisk stockpiling over double
read moreUniversities that do not improve on fulfilling their legal obligation to report clinical trials over the next six months could be brought in front of the House of Commons Science and Technology Committee to explain why they have failed to
read moreNHS England has begun to roll out its NHS App to the public, in a move hailed by doctors’ leaders as “a significant and constructive step forward in using technology to support patients”. More: RCGP welcomes roll out of NHS
read moreGSK investors cheered when the company said it would finally spin off its consumer unit after swallowing Pfizer’s. But its other December deal—a $5 billion Tesaro buyout—didn’t sit quite so well. Now, it’s a different story, one executive said in
read moreMerck KGaA chairman and CEO Stefan Oschmann has made bullish comments about China’s biopharma sector on several occasions. But now, in a somewhat surprising assessment, he counts China among three of the world’s best-working ecosystems for innovation. More: Merck KGaA
read more© 1994 - 2026 B.M. Pharmaceuticals